➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018578

Email this page to a colleague

« Back to Dashboard

NDA 018578 describes SSD AF, which is a drug marketed by Dr Reddys La and is included in one NDA. It is available from four suppliers. Additional details are available on the SSD AF profile page.

The generic ingredient in SSD AF is silver sulfadiazine. There are twenty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the silver sulfadiazine profile page.
Summary for 018578
Tradename:SSD AF
Applicant:Dr Reddys La
Ingredient:silver sulfadiazine
Formulation / Manufacturing:see details
Pharmacology for NDA: 018578
Medical Subject Heading (MeSH) Categories for 018578
Suppliers and Packaging for NDA: 018578
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SSD silver sulfadiazine CREAM;TOPICAL 018578 NDA Dr Reddys Laboratories Inc 43598-210 43598-210-25 25 g in 1 TUBE (43598-210-25)
SSD silver sulfadiazine CREAM;TOPICAL 018578 NDA Dr Reddys Laboratories Inc 43598-210 43598-210-40 400 g in 1 JAR (43598-210-40)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Feb 25, 1982TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength1%
Approval Date:Jul 11, 1990TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.